An innovative biopharmaceutical company

with integrated commercialization platform

spanning the entire biologics value chain


Serve the wellbeing of patients around the world 

through leading advancement in biomedical technologies

Tasly Biopharma focuses on global cutting-edge biotechnology, from product innovation to scientific research platform innovation, and always pursues the values of “Patient Focus: Serve the patients’ unmet needs with a focus on quality of life”. We have always been driven by innovative drug research and development and are supported by the international and integrated commercialization platforms for biologic drugs to lead and promote the future development of the industry, so as to ensure innovative biologic drugs with higher accessibility, high quality and affordable prices can benefit human health.


Become China’s most trusted biomedical technologies treatment provider covering major disease areas

We focus on three major therapeutic areas, namely, cardiovascular diseases, oncology and autoimmune diseases, and alimentary tract and metabolism, always pursue “Patient Focus: Serve the patients’ unmet needs with a focus on quality of life” and continue to create health values for patients, physicians and the society to strive to become the most trusted biologics brand to physicians and patients. We have always been using biologic drugs and biological treatments as means to develop high-quality and more accessible combined solutions to fill the unmet clinical needs of China and the world at large and become a pioneer deeply rooted in the fast growing biologics market in China.